To evaluate through a systematic review and meta-analysis the malignancy rates of thyroid incidentalomas identified in adults by 18-fluorodeoxyglucose positron emission tomography, computed tomography (18-FDG PET-CT) imaging studies.
Data Sources
The literature search was conducted using OVID Medline, EMBASE, the Cochrane Library, Google Scholar, Pubmed, and reference list review (inception to April 2013) by 2 independent review authors.
Review Methods
Studies with adults undergoing 18-FDG PET scan identifying a thyroid incidentaloma with definitive histological or cytological results reported were included.
Results
Thirty-one studies with a total of 197,296 PET studies and 3659 focal thyroid incidentalomas were identified with 1341 having definitive cytopathology or histopathology. The pooled proportion of malignancy was calculated as 19.8% (95% confidence interval [CI], 15.3%-24.7%) with 15.4% (95% CI, 11.4%-20.0%) of the total cases being papillary thyroid cancer. Distant metastases represented 1.1% (95% CI, 0.6%-1.8%) of the total cases.
Conclusions
Our systematic review and meta-analysis suggests that the incidence of malignancy is high in thyroid incidentalomas identified through 18-FDG PET imaging studies. Thyroid incidentalomas identified through 18-FDG PET require thorough investigation.
KungBTWongCPChuKSAuYongTKTongCM. Cancer risk of focal thyroid incidentaloma in patients undergoing 18f-fluorodeoxyglucose positron emission tomography–computed tomography studies: local experience in a single centre. J Hong Kong Col Radiol. 2010;13:120-124.
2.
LiuYGhesaniNZuckierLS. Physiology and pathophysiology of incidence findings detected on 18f-fluorodeoxyglucose positron emission tomography scintigraphy. Semin Nucl Med. 2010;40:294-315.
3.
ShiePCardarelliRSprawlsKFuldaKGTaurA. Systematic review: prevalence of malignant incidental thyroid nodules identified on fluorine-18 fluorodeoxyglucose positron emission tomography. Nucl Med Comm. 2009;30:742-748.
4.
RigoPPaulusPKaschtenBJ. Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose. Eur J Nucl Med. 1996;23:1641-1674.
5.
NishimoriHTabahRHickesonMHowJ. Incidental thyroid “PETomas”: clinical significance and novel description of the self-resolving variant of focal FDG-PET thyroid uptake. Can J Surg. 2011;54:83-88.
6.
MitchellJParangiS. Thyroid incidentaloma: an increasingly frequent consequence of radiologic imaging. Semin Ultrasound CT MRI. 2005;26:37-46.
7.
EzzatSSartiDACainDRBraunsteinGD. Thyroid incidentalomas. Prevalence by palpation and ultrasonography. Arch Intern Med. 1994;154:1838-1840.
8.
SilverRJParangiS. Management of thyroid incidentalomas. Surg Clin N Am. 2004;84:907-919.
9.
LiberatiAAltmanDGTetzlaffJ. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009;62:e1-e34.
10.
StroupDFBerlinJAMortonSC. Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA. 2009;283:2008-2012.
11.
SlimKNiniEForestierDKwiatkowskiFPanisYChipponiJ. Methodological index for non-randomized studies (MINORS): development and validation of a new instrument. ANZ J Surg Sept. 2003;73:712-716.
DerSimonianRLairdN. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177-188.
14.
GreenlandSRobinsJM. Estimation of common effect parameter from sparse follow up data. Biometrics. 1985;41:55-68.
15.
ChenWParsonsMTorgianDA. Evaluation of thyroid FDG uptake incidentally identified on FDG-PET/CT imaging. Nucl Med Commun. 2009;30:240-244.
16.
IshimoriTPatelP.WahlR. Detection of unexpected additional primary malignancies with PET/CT. J Nucl Med. 2005;46:752-757.
17.
KimTYKimWBRyuJS. Fluorodeoxyglucose uptake in thyroid from positron emission tomogram (PET) for evaluation in cancer patients: high prevalence of malignancy in thyroid PET incidentaloma. Laryngoscope. 2005;115:1074-1078.
18.
PrichardRSCotterMEvoyD. Focal thyroid incidentalomas identified with whole-body FDG-PET warrant further investigation. Ir Med J. 2011;104:177-179.
19.
ChoiJLeeKSKimHJ. Focal thyroid lesions incidentally identified by integrated 18F-FDG PET/CT: clinical significance and improved characterization. J Nucl Med. 2006;47:609-615.
20.
OhbaKNishizawaSMatsushitaA. High incidence of thyroid cancer in focal thyroid incidentaloma detected by 18F-fluorodexyglucose positron emission tomography in relatively young healthy subjects: results of 3-year follow-up. Endocrine J. 2010;57:395-401.
21.
KingDLStackBCSpringPMWalkerRBoedennerDL. Incidence of thyroid carcinoma in fluorodeoxyglucose positron emission tomography-positive thyroid incidentalomas. Otolaryngol Head Neck Surg. 2007;137:400-404.
22.
BeattyJSWilliamsHTAldridgeBAHughesMPVasudevaVSGucwaAL. Incidental PET/CT findings in the cancer patient: How should they be managed?Surgery. 2009;146:274-281.
23.
BaeJSChaeBJParkWC. Incidental thyroid lesions detected by FDG-PET/CT: prevalence and risk of thyroid cancer. World J Surg Oncol. 2009;7:63.
24.
ChuQDConnorSLilienDL. Positron emission tomography (PET) positive thyroid incidentaloma: the risk of malignancy observed in a tertiary referral center. Am Surg. 2006;3:272-275.
25.
Even-SapirELermanHGutmanM. The presentation of malignant tumours and pre-malignant lesions incidentally found on PET-CT. Eur J Nucl Med Mol Imaging. 2006;33:541-552.
26.
ChenYKDingHYChenKT. Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18f- fluorodeoxyglucose positron emission tomography for cancer screening in healthy subjects. Anticancer Research. 2005;25:1421-1426.
27.
KangKWKimSKKangHS. Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18f- fluorodeoxyglucose positron emission tomography for metastasis evaluation and cancer screening in healthy subjects. J Clin Endocrinol Metabol. 2003;88:4100-4104.
28.
CohenMSArslanNDehdashtiF. Risk of malignancy in thyroid incidentalomas identified by fluorodeoxyglucose-positron emission tomography. Surgery. 2001;130:941-946.
29.
KimBHNaMAKimIJKimSJKimYK. Risk stratification and prediction of cancer of focal thyroid fluorodeoxyglucose uptake during cancer evaluation. Ann Nucl Med. 2010;24:721-728.
30.
HsiehHJLinSHYangBHChuY-KChangCPLiuRS. The clinical relevance of thyroid incidentalomas detected by 18f-fluorodeoxyglucose positron emission tomography. Ann Nucl Med Sci. 2003;16:53-58.
31.
WongCLinMChiccoABensonR. The clinical significance and management of incidental focal FDG uptake in the thyroid gland on positron emission tomography/computed tomography (PET/CT) in patients with non-thyroidal malignancy. Acta Radiologica. 2011;52:899-904.
32.
EloyJABrettEMFatterpekarGM. The significance and management of incidental 18f-fluorodeoxyglucose-positron emission tomography uptake in the thyroid gland patients with cancer. Am J Neuroradiol. 2009;30:1431-1434.
33.
PaganoLSamaMTMoraniF. Thyroid incidentaloma identified by 18f-fluorodeoxyglucose positron emission tomography with CT (FDG-PET/CT): clinical and pathological relevance. Clin Endocrinol (Oxf). 2011;75:528-534.
34.
KwakJYKimEYYunM. Thyroid incidentalomas identified by 18f-fdeg pet: sonographic correlation. Am J Roentgenol. 2008;191:598-603.
35.
NilssonILArnbergFZedeniusJSundinA. Thyroid incidentaloma detected by fluorodeoxyglucose positron emission tomography/computed tomography: practical management algorithm. World J Surg. 2011;35:1291-1294.
36.
BogsrudTVKarantanisDNathanMA. The value of quantifying 18F-FDG uptake in thyroid nodules found incidentally on whole-body PET–CT. Nucl Med Commun. 2007;28:373-381.
37.
NamSYRohJLKimJSLeeJHChoiSHKimSY. Focal uptake of (18)F-fluorodeoxyglucose by thyroid in patients with nonthyroidal head and neck cancers. Clin Endocrinol (Oxf). 2007;67:135-139.
38.
KangBJOJYBaikJHJungSLParkYHChungSK. Incidental thyroid uptake on F-18 FDG PET/CT: correlation with ultrasonography and pathology. Ann Nucl Med. 2009;23:729-737.
39.
BonabiSSchmidtFBroglieMAHaileSRStockeliSJ. Thyroid incidentalomas in FDG-PET/CT: prevalence and clinical impact. Eur Arch Otorhinolaryngol. 2012;269:2555-2560.
40.
BoeckmannJBartelTSiegelEBodennerDStackBC. Can the pathology of a thyroid nodule be determined by positron emission tomography uptake?Otolaryngol Head Neck Surg. 2012;146:906-912.
41.
LeeWMKimBJKimMH. Characteristics of thyroid incidentalomas detected by pre-treatment 18F-FDG PET or PET/CT in patients with cervical cancer. J Gynecol Oncol. 2012;23:43-47.
42.
KaoYHLimSSOngSC. Thyroid incidentalomas on fluorine-18-fluorodeoxyglucose positron emission tomography-computed tomography: incidence, malignancy risk, and comparison of standardized uptake values. Can Assoc Radiol J. 2012;63:289-295.
43.
BertagnaFTregliaGPiccardoAGiovanniniE. F18-FDG-PET/CT thyroid incidentalomas: a wide retrospective analysis in three Italian centres on the significance of focal uptake and SUV value. Endocrine. 2013;43:678-685.
44.
Van Den BruelAMaesADe PotterT. Clinical relevance of thyroid fluorodeoxyglucose-whole body positron emission tomography incidentaloma. J Clin Endocrinol Metab. 2002;87:1517-1520.
45.
SalvatoriMMelisLCastaldiP. Clinical significance of focal and diffuse thyroid diseases identified by (18)F-fluorodeoxyglucose positron emission tomography. Biomed Pharmacother. 2007;61:488-493.
46.
AgressHJrCooperBZ. Detection of clinically unexpected malignant and premalignant tumors with whole-body FDG PET: histopathologic comparison. Radiology. 2004;230:417-422.
47.
SnenMDeckerGLasarYPilloyWBerchemG. [Early detection of synchronous thyroid carcinoma and malignant melanoma by fluorodeoxyglucose positron emission tomography].[Article in French]. Bull Soc Sci Med Grand Duche Luxemb. 2003;(2):111-115.
48.
BertagnaFGiubbiniR. F18-FDG-PET/CT thyroid incidentalomas and their benign or malignant nature: a critical and debated issue. Ann Nucl Med. 2011;25:151-152.
49.
TakekawaSKodairaYBabaM. Multiple and incidentally found cancers detected by 18F-FDG positron emission tomography/CT at one examination. Fukushima J Med Sci. 2007;53:109-118.
50.
YiJGMaromEMMundenRF. Focal uptake of fluorodeoxyglucose by the thyroid in patients undergoing initial disease staging with combined PET/CT for non-small cell lung cancer. Radiology. 2005;236:271-275.
51.
RamosCDChisinRYeungHWLarsonSMMacapinlacHA. Incidental focal thyroid uptake on FDG positron emission tomographic scans may represent a second primary tumor. Clin Nucl Med. 2001;26:193-197.
52.
MakisWHickesonMNovales-DiazJA. Interesting image. Unsuspected synchronous thyroid carcinoma revealed on a post-therapy F-18 FDG PET/CT, in a patient with follicular lymphoma. Clin Nucl Med. 2010;35:879-881.
53.
HsuCHWuCHChuJS. Metastatic cancer in thyroid detected by FDG PET. Clin Nucl Med. 2006;31:51-52.
54.
KimMSSimYSLeeSYJeonDG. Occult thyroid carcinoma detected by FDG-PET scan in elderly osteosarcoma patients: report of two cases. Ann Nucl Med. 2007;21:529-532.
55.
ParesiRJCunto-AmestyGShahD. Thyroid incidentalomas on positron emission tomography: Is further workup necessary?Surgical Rounds. 2008.
56.
LiuY. Clinical significance of thyroid uptake on F18-fluorodeoxyglucose positron emission tomography. Ann Nucl Med. 2009;23:17-23.
57.
SilverRJParangiS. Management of thyroid incidentalomas. Surg Clin North Am. 2004;84:907-919.
58.
RigoPPaulusPKaschtenBJ. Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose. Eur J Nucl Med. 1996;23:1641-1674.
59.
LiuYGhesaniNVZuckierLS. Physiology and pathophysiology of incidental findings detected on FDG-PET scintigraphy. Semin Nucl Med. 2010;40:294-315.
60.
ShiePCardarelliRSprawlsKFuldaKGTaurA. Systematic review: prevalence of malignant incidental thyroid nodules identified on fluorine-18 fluorodeoxyglucose positron emission tomography. Nucl Med Commun. 2009;30:742-748.
61.
MitchellJParangiS. The thyroid incidentaloma: an increasingly frequent consequence of radiologic imaging. Semin Ultrasound CT MR. 2005;26:37-46.
62.
IyerNGShahaARSilverCE. Thyroid incidentalomas: to treat or not to treat. Eur Arch Otorhinolaryngol. 2010;267:1019-1026.
63.
HanYMKimYCParkEKChoeJG. Diagnostic value of CT density in patients with diffusely increased FDG uptake in the thyroid gland on PET/CT images. Am J Roentgenol. 2010;195:223-228.
64.
WangGLauEWShakherR. How do oncologists deal with incidental abnormalities on whole-body fluorine-18 fluorodeoxyglucose PET/CT?Cancer. 2007;109:117-124.
65.
BeattyJSWilliamsHTAldridgeBA. Incidental PET/CT findings in the cancer patient: how should they be managed?Surgery. 2009;146:274-281.
66.
OzkolVAlperEAydinN. The clinical value of incidental 18F-fluorodeoxyglucose-avid foci detected on positron emission tomography/computed tomography. Nucl Med Commun. 2010;31:128-136.
67.
WangEHLauEWFShakherR. Clinical significance of 18F-FDG PET/CT whole body imaging in detecting incidental abnormalities in cancerous patients. Chinese J Nucl Med. 2007;27(1).
68.
MüssigKOksüzMO. [Incidental thyroidal tracer uptake [corrected] during [18F]-fluorodeoxyglucose positron emission tomography]. [Article in German]. Dtsch Med Wochenschr. 2009;134:1585-1586.
69.
KarantanisDBogsrudTVWisemanGA. Clinical significance of diffusely increased 18F-FDG uptake in the thyroid gland. J Nucl Med. 2007;48:896-901.
70.
JinJWilhelmSMMcHenryCR. Incidental thyroid nodule: patterns of diagnosis and rate of malignancy. Am J Surg. 2009;197:320-324.
71.
AreCHsuJFSchoderHShahJPLarsonSMShahaAR. FDG-PET detected thyroid incidentalomas: need for further investigation?Ann Surg Oncol. 2007;14:239-247.
72.
IbarraJMVillaMLSantiagoJY. Prevalence of malignancy in patients with thyroid incidentalomas detected by 18F-fluorodeoxyglucose positron emission tomography. Phil J Internal Medicine. 2009;47:71-75.
73.
WolfGAignerRMSchafflerGSchwarzTKripplP. Pathology results in [18F]fluorodeoxyglucose positron emission tomography of the thyroid gland. Nucl Med Commun. 2003;24:1225-1230.
74.
HoTYLiouMJLinKJYenTC. Prevalence and significance of thyroid uptake detected by 18F-FDG PET. Endocrine. 2011;40:297-302.
75.
WongLQBalochZW. Analysis of the Bethesda system for reporting thyroid cytopathology and similar precursor thyroid cytopathology reporting schemes. Adv Anat Pathol. 2012;19:313-319.
76.
YangJSchnadigVLogronoR. Fine-needle aspiration of thyroid nodules: a study of 4703 patients with histologic and clinical correlations. Cancer. 2007;111:306-315.
77.
PianaSFrasoldatiAFerrariM. Is a five-category reporting scheme for thyroid fine needle aspiration cytology accurate? Experience of over 18,000 FNAs reported at the same institution during 1998-2007. Cytopathology. 2011;22:164-173.
78.
RoriveSD’HaeneNFossionC. Ultrasound-guided fine-needle aspiration of thyroid nodules: stratification of malignancy risk using follicular proliferation grading, clinical and ultrasonographic features. Eur J Endocrinol. 2010;162:1107-1115.
79.
BohacekLMilasMMitchellJ. Diagnostic accuracy of surgeon-performed ultrasound-guided fine-needle aspiration of thyroid nodules. Ann Surg Oncol. 2012;19:45-51.
80.
KimSKHwangTSYooYB. Surgical results of thyroid nodules according to a management guideline based on the BRAF(V600E) mutation status. J Clin Endocrinol Metab. 2011;96:658-664.
81.
SinnaEAEzzatN. Diagnostic accuracy of fine needle aspiration cytology in thyroid lesions. J Egypt Natl Canc Inst. 2012;24:63-70.
82.
CooperDSDohertyGMHaugenBR. Revised American Thyroid Association guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19:1167-1214.
83.
AbrahamTSchöderH. Thyroid cancer—indications and opportunities for positron emission tomography/computed tomography imaging. Semin Nucl Med. 2011;41:121-138.
84.
PampaloniMHWinAZ. Prevalence and characteristics of incidentalomas discovered by whole body FDG PETCT. Int J Mol Imaging. 2012;2012:476763.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
